CLINICAL EFFICACY OF GABAPENTIN VERSUS TIAGABINE FOR REDUCING COCAINE USE AMONG COCAINE DEPENDENT METHADONE TREATED PATIENTS
Gorde:
GONZALEZ, G., ET AL., CLINICAL EFFICACY OF GABAPENTIN VERSUS TIAGABINE FOR REDUCING COCAINE USE AMONG COCAINE DEPENDENT METHADONE TREATED PATIENTS. DRUG AND ALCOHOL DEPENDENCE, Vol. 87, no. 1 (2007), p. 1-9.
Erref.
146121
Kokapena:
SIIS R.854 Archivo
Hitz-gakoak:
Abstinencia, Cocaína, Drogodependencias, Estudio epidemiológico, Fármacos, Metadona, Programas de mantenimiento, Resultados
Abstinencia, Cocaína, Drogodependencias, Estudio epidemiológico, Fármacos, Metadona, Programas de mantenimiento, Resultados
Antzeko izenburuak: CLINICAL EFFICACY OF GABAPENTIN VERSUS TIAGABINE FOR REDUCING COCAINE USE AMONG COCAINE DEPENDENT METHADONE TREATED PATIENTS
- TIAGABINE INCREASES COCAINE-FREE URINES IN COCAINE-DEPENDENT METHADONE-TREATED PATIENTS. RESULTS OF A RANDOMIZED PILOT STUDY
- AMANTADINE DOES NOT REDUCE COCAINE USE OR CRAVING IN COCAINE-DEPENDENT METHADONE MAINTENANCE PATIENTS
- DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE IN BUPRENORPHINE- OR METHADONE-TREATED PATIENTS: BASELINE URINE RESULTS AS PREDICTOR OF RESPONSE
- COST EFFECTIVENESS OF DISULFIRAM: TREATING COCAINE USE IN METHADONE-MAINTAINED PATIENTS
- TREATING COCAINE-USING METHADONE PATIENTS: PREDICTORS OF OUTCOMES IN A PSYCHOSOCIAL CLINICAL TRIAL
- FOLLOW-UP OF INPATIENT COCAINE WITHDRAWAL FOR COCAINE-USING METHADONE PATIENTS